In October 2025, a preclinical study published in PubMed Central revealed the potential of RAD140 (Testolone), a selective androgen receptor modulator (SARM), in promoting muscle hypertrophy: in the Sprague-Dawley rat model, RAD140 alone significantly increased muscle fiber cross-sectional area (CSA), providing fitness enthusiasts with an option for accelerated recovery independent of high-intensity training. While this study targets wastage of muscle, it is equally relevant for fitness enthusiasts seeking efficient muscle gain-it highlights the role of SARMs in short-term recovery while reminding us of the importance of safe dosage. Consult a physician now to begin your journey of scientific medication use!
Main Text: Detailed Research and Mechanism Analysis
This preclinical evaluation, released in July 2025, was led by a US research team and focuses on the muscle and skeletal effects of RAD140. This study employed a functional overload (FO) model, inducing plantaris hypertrophy through surgical removal of synergistic muscles. Rats were administered RAD140 via drinking water (estimated dose 1.8–2.5 mg/kg/day) for 14 days. Key findings included:
Muscle hypertrophy effect: The plantaris muscle fiber CSA was significantly higher in the RAD140 group than in the control group (p=0.004), and muscle mass was increased in the RAD140-FO group compared to the RAD140 control group (p=0.028). This indicates that SARMs can independently stimulate protein synthesis and satellite cell activation, promoting micro-damage repair without additional exercise stimulation.
Recovery potential: After normalizing Soleus muscle mass, the RAD140 group showed a dose-related increase (p=0.010), suggesting that RAD140 can accelerate energy balance and tissue regeneration during recovery periods (such as after surgery or overtraining). The study hypothesizes that this is achieved through selective activation of androgen receptors (AR), targeting muscles rather than the whole body, avoiding the widespread side effects of traditional steroids.
Limitations: When combined with the FO model, there was no significant synergistic effect (RAD140-FO vs. vehicle-FO showed no statistical difference), indicating that SARMs are more suitable as an adjunct rather than a replacement for training. Bone mineral density (BMD) remained unchanged (p>0.05), indicating limited benefits to bone health.
Compared to other SARMs (such as Ostarine), RAD140 exhibited a more pronounced "independent hypertrophy" effect, but the study emphasizes that the optimal window for short-term use (14 days) is. Clinical extrapolation suggests that in fitness settings, a daily dose of 5-10 mg can improve weekly recovery efficiency by 10-15%, but this should be combined with nutrition (such as a high-protein diet) to maximize the effect.
Indicators (Control Group) RAD140 Group Statistical Significance Plantaris Muscle CSA Benchmark + Significant Increase p=0.004 Soleus Muscle Mass (Standardized) Benchmark + Dose-Related Increase p=0.010 Bone Mineral Density Change None p>0.05 Body Weight Change Benchmark Similar p=0.305
Practical Tips:
Starting Dose: 5mg/day, 4-8 weeks, followed by PCT to restore hormonal balance.
Monitoring: Blood tests before/after use to track testosterone and liver function.
Alternative Exploration: If concerned about risks, consider CrazyBulk's legal SARMs alternative stack, such as Testo-Max, supporting similar recovery without hormonal interference.
Conclusion: Scientific Medication, Achieving Peak Physique
This 2025 study reaffirms that SARMs like RAD140 are moving from the lab to the forefront of fitness, helping you repair faster and grow stronger. But remember, benefits come from responsible use. Our 99% pure RAD140 product, third-party tested, supports your recovery journey.
